o NoneEntity Type
0001213037
USED KAR PARTS INC
Trovagene, Inc.
TrovaGene Inc.
XENOMICS INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Cardiff Oncology, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Cardiff Oncology, Inc. 
Street Address 1Street Address 2
 11055 Flintkote Avenue 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 San Diego CALIFORNIA 92121 (858) 952-7570 



3. Related Persons
Last NameFirst NameMiddle Name
Adams, Ph.D.Thomas
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Erlander, Ph.D.Mark
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Executive Officer

Last NameFirst NameMiddle Name
BrancaccioJohn
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Jacob, Ph.D.Gary
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
MarkinRodney
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
ArmitageJames
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
WhiteLale
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Pace, Ph.D.Gary
Street Address 1Street Address 2
11055 Flintkote Avenue
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92121
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-05-12 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 810000 USD o Indefinite
Total Amount Sold $ 810000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 8


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
TrovaGene (NASDAQ:TROV)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos TrovaGene.
TrovaGene (NASDAQ:TROV)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos TrovaGene.

Notícias Cardiff Oncology, Inc.

Notícias em tempo-real sobre TrovaGene Inc da NASDAQ bolsa de valores: 0 artigos recentes

Mais Notícias de Cardiff Oncology, Inc.